Abstract
We have previously demonstrated that the lethal effects of free radicals generated by intravenous administration of Xanthine (X: 0.225 mg kg−1) and Xanthine Oxidase (XO: 5 u kg−1) were prevented by calcium channel blockers such as felodipine (a dihydropyridine calcium antagonist) and verapamil. These studies have implicated that there may be potential interactions between free radicals and cell calcium. However, alternate mechanisms such as hemodynamic changes in the overall effects of calcium antagonists cannot be ruled out. Therefore, the present studies are conducted to further investigate the efficacy of various cardiovascular agents such as Dopexamine (DPX) on [X+XO]-induced mortality.
Intravenous administration of [X+XO] to anesthetized rats produced a rapid decrease in blood pressure and a mortality rate of over 90%. Pretreatment with dopexamine, a dopamine receptor (DA1) and \2 adrenoceptor agonist significantly enhanced survival upto 70%. Neither dobutamine nor prenalterol, (preferential β1 agonists) both of which produced similar increases in heart rate as DPX, enhanced survival rate thus suggesting that cardiac stimulation alone, did not contribute to the protective effects of DPX. Likewise, fenoldopam, a DA1, agonist and a vasodilator also failed to have any significant protective effect on [X+XO]-induced mortality suggesting that the DA1 receptor activation alone cannot account for the salutary effects of dopexamine. Pretreatment of the rats with Salbutamol, a preferential \2 agonist significantly enhanced survival upto 50% and a \2 antagonist ICI 118,551 significantly attenuated the ability of dopexamine to promote survival. These observations suggest that activation of \2 adrenoceptors by dopexamine may play a primary role in the protective effects of DPX; however potential involvement of additional mechanisms in this effect cannot be ruled out at this time.
Similar content being viewed by others
References
Akhtar N, Mikulic E, Cohn JN, Chaudhary MH (1975) Hemodynamic effect of dobutamine in patients with severe heart failure. Am J Cardiol 36:202–205
Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, McKay PB (1989) Direct evidence that oxygen-derived free radicals contribute to post-ischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 86:4695–4699
Brown RA, Farmer JB, Hall JC, Humphries RG, O'Connor SE, Smith GW (1985a) The effects of dopexamine on the cardiovascular system of the dog. Br J Pharmacol 85:609–619
Brown RA, Dixon J, Farmer JB, Hall JC, Humphries RG, Ince F, O'Connor SE, Simpson WT, Smith GW (1985b) Dopexamine: a novel agonist at peripheral dopamine receptors and \2-adrenoreceptors. Br J Pharmacol 85:599–608
Burton KP, McCord JM, Ghai G (1984) Myocardial alterations due to free radical generation. Am J Physiol 246:H776-H783
Chintala MS, Lokhandwala MF, Jandhyala BS (1990) Protective effects of dopexamine hydrochloride in renal failure after acute hemorrhage in anesthetized dogs. J Anton Pharmacol 10 [Suppl]:S95-S102
Chintala MS, Jacinto SM, Jandhyala BS (1992) Studies on the deleterious effects of free radicals on myocardial contractility and hemodynamics in dogs: Protection by felodipine, a dihydropyridine calcium antagonist. Drug Dev Res 27:227–295
Chintala MS, Moore RJ, Lokhandwala MIT, Jandhyala BS (1993) Evaluation of the effects of dopexamine, a novel DA1 receptor and \2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock. Naunyn-Schmiedeberg's Arch Pharmacol 347:396–300
Corretti MC, Koretsune Y, Jusuoka H, Chacko VP, Zweier JL, Marban E (1991) Glycolytic inhibition and calcium overload as consequences of exogenously-generated free radicals in rabbit hearts. J Clin Invest 88:1014–1025
Crowell JW, Jones CE, Smith EE (1969) Effect of allopurinol on hemorrhagic shock. Am J Physiol 216:744–748
Farmer JB (1991) Research into the cardiovascular effects of dopexamine hydrochloride. Clin Inten Care 2[Suppl]:9–11
Farber JL, Kyls ME, Coleman JB (1990) Biology of disease, mechanisms of cell injury by activated oxygen species. Lab Invest 62:670–679
Goldhaber JL, Ji S, Lamp ST, Weiss JN (1989) Effect of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricles. J Clin Invest 83:1800–1809
Gupta M, Singal PK (1989) Time course of structure, function and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol 67:1549–1559
Hammond B, Kontos HA, Hess ML (1985) Oxygen radicals in adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage. Can J Physiol Pharmacol 63:173–187
Hess ML, Okabe E, Kontos HA (1981) Protein and free oxygen radical interaction with the calcium transport system of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 13:767–772
Holclaw TL, Beck TR (1990) Clinical experience with intravenous fenoldopam. Am J Hypertens 3:120S-125S
Jacinto SM, Jandhyala BS (1992) Evaluation of the effects of felodipine, verapamil and hydralazine on the survival rate of rats subjected to lethal effects of oxygen free radicals. Naunyn-Schmiedeberg's Arch Pharmacol 346:457–461
Jaski BE; Wijns W, Foulds R, Serruys PW (1986) The haemodynamic and myocardial effects of dopexamine: a new \2-adrenoceptor and dopamine agonist. Br J Clin Pharmacol 21:393–400
Lars EK, Bjorkman J-A, Jandhyala BS (1985) Effects of Prenalterol, a partial beta adrenoceptor agonist, on the left ventricular function in anesthetized cardiac denervated beagle dogs. Drug Dev Res 5:371–378
Lokhandwala MF, Jandhyala BS (1992) Effects of dopaminergic agonists on organ blood flow and function. Clin Inten Care 3 [Suppl]:12–15
McCord JM (1985) Oxygen-derived free radicals in post-ischemic injury. New Engl J Med 312:159–163
Prasad K, Kalra J, Chan WP, Chaudhary AK (1989) Effect of oxygen free radicals on cardiovascular function at organ and cellular levels. Am Heart J 117:1196–1202
Ronn O, Graffner C, Johnsson G, Jordo L, Lundborg P, Wikstrand J (1979) Hemodynamic effects and pharmacokinetics of a new selective beta-1 andrenoceptor agonist, prenalterol and its interactions with metoprolol in man. Eur J Clin Pharmacol 15:9–13
Svendsen JH, Bjerrum PJ (1992) Effects of exogenous oxygen free radicals on myocardial capillary permeability, vascular tone, and incidence of ventricular arrhythmias in the canine heart. Cardivasc Res 26:1181–1188
Author information
Authors and Affiliations
Additional information
Correspondence to: B. S. Jandhyala at the above address
Rights and permissions
About this article
Cite this article
Jacinto, S.M., Lokhandwala, M.F. & Jandhyala, B.S. Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and β2 adrenoceptor agonist. Naunyn-Schmiedeberg's Arch Pharmacol 350, 277–283 (1994). https://doi.org/10.1007/BF00175033
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175033